• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of all recall classifications meeting 26 calendar-day timeframe in the month

Dictionary: Using the recall process, manufacturers may voluntarily remove a drug from the marketplace if a drug quality defect is found. OC classifies the recall (or recommends classification in some cases) based on the level of public health risk. A Class I recall is the most significant recall. A recall may be done for a single product dosage form or for multiple dosage forms, or multiple products.

Information is current as of March 31, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20138591
Nov 20138586
Dec 20138583
Jan 20148577
Feb 20148581
Mar 20148596
Apr 201485TBD
May 201485TBD
Jun 201485TBD
Jul 201485TBD
Aug 201485TBD
Sep 201485TBD

FY 2014 YTD: 84%

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Percentage of Class I classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 201390N/A
Nov 201390100
Dec 201390100
Jan 201490100
Feb 201490N/A
Mar 201490100
Apr 201490TBD
May 201490TBD
Jun 201490TBD
Jul 201490TBD
Aug 201490TBD
Sep 201490TBD

FY 2014 YTD: 100%

Percentage of Class II classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 20138588
Nov 20138588
Dec 20138572
Jan 20148572
Feb 20148583
Mar 201485100
Apr 201485TBD
May 201485TBD
Jun 201485TBD
Jul 201485TBD
Aug 201485TBD
Sep 201485TBD

FY 2014 YTD: 81%

Percentage of Class III classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 201380100
Nov 20138075
Dec 20138089
Jan 20148067
Feb 20148075
Mar 20148083
Apr 201480TBD
May 201480TBD
Jun 201480TBD
Jul 201480TBD
Aug 201480TBD
Sep 201480TBD

FY 2014 YTD: 81%

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.